Heavy/light chain ratio normalization prior to transplant is of independent prognostic significance in multiple myeloma: a BMT CTN 0102 correlative study.
Medical College of Wisconsin, Milwaukee, WI, USA.
Anita
A
D'Souza
Medical College of Wisconsin, Milwaukee, WI, USA.
Marcelo
M
Pasquini
Medical College of Wisconsin, Milwaukee, WI, USA.
Brent
B
Logan
Memorial Sloan-Kettering Cancer Center, New York, NY, USA.
Sergio
S
Giralt
City of Hope Cancer Center, Los Angeles, CA, USA.
Amrita
A
Krishnan
Dana-Farber Cancer Institute, Boston, MA, USA.
Joseph
J
Antin
National Marrow Donor Program, Minneapolis, MN, USA.
Alan
A
Howard
Vanderbilt University Medical Center and Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN, USA.
Stacy
S
Goodman
MD Anderson Cancer Research Center, Houston, TX, USA.
Muzzafar
M
Qazilbash
The EMMES Corporation, Rockville, MD, USA.
Kristin
K
Knust
City of Hope Cancer Center, Los Angeles, CA, USA.|Southern California Kaiser Permanente Medical Group, Los Angeles, USA.
Firoozeh
F
Sahebi
University of Minnesota, Minneapolis, MN, USA.
Daniel
D
Weisdorf
Hackensack University Medical Center, Hackensack, NJ, USA.
David
D
Vesole
University of Pennsylvania Abramson Cancer Center, Philadelphia, PA, USA.
Edward
E
Stadtmauer
Fred Hutchison Cancer Center, Seattle, WA, USA.
David
D
Maloney
Medical College of Wisconsin, Milwaukee, WI, USA.
Parameswaran
P
Hari
D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000235:genetics*; D007147:Immunoglobulin Light Chains / Q000235:genetics*; D009101:Multiple Myeloma / Q000175:diagnosis / Q000235:genetics* / Q000401:mortality* / Q000628:therapy; D011379:Prognosis; D016019:Survival Analysis; D014182:Transplantation, Autologous; D014184:Transplantation, Homologous; D016896:Treatment Outcome
D007143:Immunoglobulin Heavy Chains; D007147:Immunoglobulin Light Chains
freelite; hevylite; myeloma